Alternative Dosing of Omalizumab as an Adjunct Therapy During Multiallergen Oral Immunotherapy in Food Allergic Patients

Journal of Allergy and Clinical Immunology - United States
doi 10.1016/j.jaci.2018.12.749
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Predictors of Allergic Symptoms and Anaphylaxis During Peanut Oral Immunotherapy

Journal of Allergy and Clinical Immunology
AllergyImmunology
2019English

Short-Course Oral Steroids as an Adjunct Therapy for Chronic Rhinosinusitis

2015English

Omalizumab in the Prevention of Anaphylaxis During Immunotherapy: A

Postepy Dermatologii I Alergologii
DermatologyAllergyImmunology
2014English

Efficacy of Long-Term Sublingual Immunotherapy as an Adjunct to Pharmacotherapy in House Dust Mite-Allergic Children With Asthma

Pediatrics
Child HealthPediatricsPerinatology
2008English

Omalizumab: A Potential Therapy Option for Allergic Bronchopulmonary Aspergillosis (ABPA) in Asthma Patients

Journal of Allergy and Clinical Immunology
AllergyImmunology
2019English

Towards Safer Oral Immunotherapy for Food Allergy and Allergic Asthma Is Still Increasing in Prevalence

Clinical and Experimental Allergy
AllergyImmunology
2017English

Corticosteroids as an Adjunct to Tuberculosis Therapy

Expert Review of Respiratory Medicine
ImmunologyPublic HealthAllergyEnvironmentalPulmonaryRespiratory MedicineOccupational Health
2018English

Real-Life Effectiveness of Omalizumab in Severe Allergic Asthma Above the Recommended Dosing Range Criteria

Pediatrics
Child HealthPediatricsPerinatology
2017English

Oral Immunotherapy for Food Allergy

Journal of Investigational Allergology and Clinical Immunology
AllergyImmunology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy